MICHELE LIVELY: Open Payments
NPI 1437116241 · GEORGETOWN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 49 payments from 20 companies in 2025. Trend: 2023 $1,185 · 2024 $1,265 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $177 |
| AstraZeneca Pharmaceuticals LP | 8 | $142 |
| CVRx, Inc. | 2 | $127 |
| Novo Nordisk Inc | 5 | $107 |
| Exact Sciences Corporation | 4 | $80 |
| Supernus Pharmaceuticals, Inc. | 1 | $80 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $57 |
| Corcept Therapeutics | 2 | $47 |
| PFIZER INC. | 2 | $39 |
Products named: OTEZLA, Barostim Neo System, Ozempic, Cologuard Collection Kit, Qelbree, FARXIGA, Kerendia, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
